.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
Express Scripts
Colorcon
Queensland Health
Harvard Business School
Accenture
UBS
QuintilesIMS
Federal Trade Commission
Moodys

Generated: July 22, 2017

DrugPatentWatch Database Preview

TAZIDIME IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

What is the patent landscape for Tazidime In Plastic Container, and when can generic versions of Tazidime In Plastic Container launch?

Tazidime In Plastic Container is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in TAZIDIME IN PLASTIC CONTAINER is ceftazidime. There are seventeen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.

Summary for Tradename: TAZIDIME IN PLASTIC CONTAINER

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list28
Clinical Trials: see list460
Patent Applications: see list5,281
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TAZIDIME IN PLASTIC CONTAINER at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
TAZIDIME IN PLASTIC CONTAINER
ceftazidime
INJECTABLE;INJECTION062739-001Jul 10, 1986DISCNNoNo► Subscribe► Subscribe
Lilly
TAZIDIME IN PLASTIC CONTAINER
ceftazidime
INJECTABLE;INJECTION062739-002Jul 10, 1986DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Baxter
Johnson and Johnson
AstraZeneca
US Department of Justice
Novartis
Argus Health
Dow
Farmers Insurance
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot